Immunosuppressive Drug Regimens following Renal Transplantation: Cost and Effectiveness Analyses

National Center for Health Statistics. Health, United States, 1990. Hyattsville, MD: US Public Health Service, 1991: 184–6.

Warner KE . Cost-benefit and cost-effectiveness analysis in health care. Ann Arbor, MI: Health Administration Press, 1982: 43–57.

Manninen DL Evans RW . The costs and outcomes of kidney transplantation according to initial immunosuppressive drug protocol. In: Terasaki P , ed. Clinical transplant. Los Angeles: UCLA Tissue Typing Laboratory, 1986: 269–75.

The Canadian Multicenter Transplant Study Group. A randomized clinical trial of cyclosporine in cadaveric renal transplantation. N Engl J Med 1983; 309: 809–15.

European Multicenter Trial Group. Cyclosporine in cadaveric renal transplantation: One year follow-up of a multicenter trial. Lancet 1983; 2: 986–9.

Sutherland DER Fryd DS Strand MH , Results of the Minnesota Randomized Prospective Trial of cyclosporine versus azathioprine-antilymphocyte globulin for immunosuppression in renal allograft recipients. Am J Kidney Dis 1985; 5: 318–27.

Gaspari CK . The use and misuse of cost-effectiveness analysis. Soc Sci Med 1983; 17: 1043–6.

Fryed DS So SKS Kruse L , Improving results of renal transplantation with multidrug therapy in patients over 50 years of age. Clin Transplant 1987; 1: 75–80.

Task Force on Organ Transplantation. Report to the Secretary and the Congress on immunosuppressive therapies. Washington, DC: US Department of Health and Human Services, 1985.

Sibley RJ Rynasiewicz JJ Ferguson RM , Morphology of CSA nephrotoxicity and acute rejection in patients immunosuppressed with CSA prednisone. Surgery 1983; 94: 225–34.

Canafax DM Torres A Fryed DS , The effect of delayed function on recipients of cadaveric renal allografts. Transplantation 1986; 41: 177–81.

Johnson CP Simmons RL Sutherland DER , A randomized trial comparing cyclosporine with antilymphoblast globulin-azathioprine for renal allograft recipients. Transplantation 1988; 45: 380–5.

Squifflet JP Sutherland DER Rynasiewicz JJ Field J Heil J Najarian JS . Combined immunosuppressive therapy with cyclosporine A and azathioprine. Transplantation 1982; 34: 315–8.

Simmons RL Canafax DM Strand MH , Management and prevention of cyclosporine nephrotoxicity after renal transplantation: Use of low doses of cyclosporine, azathioprine and prednisone. Transplant Proc 1985; 17: 266–75.

Najarian JS Fryd DS Strand M , A single institution randomized prospective trial of CSA versus AZA-antilymphocyte globulin for immunosuppression in renal allograft recipients. Ann Surg 1985; 201: 142–57.

Nie HH Hull CH Jenkins JG Steinbrenner K Bent DH . Statistical package for the social sciences. 2nd ed. New York: McGraw-Hill, 1975.

Morrison DG . On interpretation of discriminant analysis. J Market Res 1969; 6: 156–63.

Davis CK Rhodes DJ . The impact of DRGs on the cost and quality of health care in the United States. Health Policy 1988; 9: 117–31.

PPS monitoring activity report. Washington, DC: US Department of Health and Human Services, 1987.